Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter February 22, 2014

Method-specific differences in β-isomerised carboxy-terminal cross-linking telopeptide of type I collagen and procollagen type I amino-terminal propeptide using two fully automated immunoassays

Gillian Wheater, Cheryl Goodrum, Stephen P. Tuck, Harish K. Datta and Jacob M. van Laar

Corresponding author: Gillian Wheater, Department of Biochemistry, The James Cook University Hospital, Middlesbrough, Cleveland, TS4 3BW, UK, Phone: +44 1642 835870, E-mail: ; and Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK

Acknowledgments

The authors wish to thank staff and volunteers from the Pathology and Rheumatology departments at the James Cook University Hospital, Middlesbrough who made this study possible. We thank Immuno-Diagnostic Systems (Boldon, UK) for providing PINP and βCTX reagents for the iSYS analyser.

Conflict of interest statement

Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article. Research support played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

Research funding: None declared.

Employment or leadership: JMvL has received a research grant, consultancy and speaker fees from Roche. SPT has received speaker fees from Ely Lilly.

Honorarium: None declared.

References

1. Wheater G, Elshahaly M, Tuck SP, Datta HK, van Laar JM. The clinical utility of bone marker measurements in osteoporosis. J Transl Med 2013;11:201.10.1186/1479-5876-11-201Search in Google Scholar

2. Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, et al. for the IOF-IFCC Bone Marker Standards Working Group. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 2011;22:391–420.10.1007/s00198-010-1501-1Search in Google Scholar

3. Stokes FJ, Ivanov P, Bailey LM, Fraser WD. The effects of sampling procedures and storage conditions on short-term stability of blood-based biochemical markers of bone metabolism. Clin Chem 2011;57:138–40.10.1373/clinchem.2010.157289Search in Google Scholar

4. Brandt J, Krogh TN, Jensen CH, Frederiksen JK, Teisner B. Thermal instability of the trimeric structure of the N-terminal propeptide of human Procollagen type I in relation to assay technology. Clin Chem 1999;45:47–53.10.1093/clinchem/45.1.47Search in Google Scholar

5. Seibel MJ, Lang M, Geilenkeuser W-J. Interlaboratory variation of biochemical markers of bone turnover. Clin Chem 2001;47:1443–50.10.1093/clinchem/47.8.1443Search in Google Scholar

6. Schafer AL, Vittinghoff E, Ramachandran R, Mahmoudi N, Bauer DC. Laboratory reproducibility of biochemical markers of bone turnover in clinical practice. Osteoporos Int 2010;21:439–45.10.1007/s00198-009-0974-2Search in Google Scholar

7. Bauer D, Krege J, Lane N, Leary E, Libanati C, Miller P, et al. National Bone Health Alliance bone turnover marker project: current practices and the need for US harmonization, standardization, and common reference ranges. Osteoporos Int 2012;23:2425–33.10.1007/s00198-012-2049-zSearch in Google Scholar

8. Cavalier E, Carlisi A, Rousselle O, Ferrante N, Chapelle J-P. Analytical performance of the IDS-iSYS Crosslaps® (CTX-1) automated immunoassay. Scientific congresses and symposiums: posters 2012. Available from: http://hdl.handle.net/2268/127876. Accessed 14 April, 2013.Search in Google Scholar

9. Koivula M-K, Ruotsalainen V, Björkman M, Nurmenniemi S, Ikäheimo R, Savolainen K, et al. Difference between total and intact assays for N-terminal propeptide of type 1 procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide. Ann Clin Biochem 2010;47:67–71.10.1258/acb.2009.009110Search in Google Scholar

10. Marin L, Koivula M-K, Jukkola-Vuorinen A, Leino A, Risteli J. Comparison of total and intact amino-terminal propeptide of type 1 procollagen assays in patients with breast cancer with or without bone metastases. Ann Clin Biochem 2011;48:447–51.10.1258/acb.2011.011040Search in Google Scholar

Received: 2013-10-29
Accepted: 2014-1-31
Published Online: 2014-2-22
Published in Print: 2014-7-1

©2014 by Walter de Gruyter Berlin/Boston